Article Details

Jazz Pharmaceuticals' epilepsy drug advances into phase 3 trial - PharmaTimes

Retrieved on: 2022-08-22 11:07:11

Tags for this article:

Click the tags to see associated articles and topics

Jazz Pharmaceuticals' epilepsy drug advances into phase 3 trial - PharmaTimes. View article details on hiswai:

Excerpt

Epidiolex, developed by GW Pharmaceuticals, is an epilepsy treatment derived from cannabidiol (CBD), a chemical component of cannabis.

Article found on: www.pharmatimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up